Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer
Titel:
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer
Auteur:
Evans, T.R.J. Van Cutsem, E. Moore, M.J. Bazin, I.S. Rosemurgy, A. Bodoky, G. Deplanque, G. Harrison, M. Melichar, B. Pezet, D. Elekes, A. Rock, E. Lin, C. Strauss, L. O’Dwyer, P.J.